Effects of Verapamil versus metoprolol to prevent progression from Paroxysmal to persistent Atrial Fibrillation

Trial Profile

Effects of Verapamil versus metoprolol to prevent progression from Paroxysmal to persistent Atrial Fibrillation

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 26 Oct 2017

At a glance

  • Drugs Verapamil (Primary) ; Metoprolol
  • Indications Atrial fibrillation
  • Focus Therapeutic Use
  • Acronyms VERAPAF
  • Most Recent Events

    • 26 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top